Current evidence on the use of probiotics in liver diseases

Chávez-Tapia, Norberto C.; González-Rodríguez, Leticia; Jeong, MinSeung; López-Ramírez, Yanine; Barbero-Becerra, Varenka J.; Juárez-Hernández, Eva; Romero-Flores, J.L.; Arrese, Marco; Méndez-Sánchez, Nahúm; Uribe, Misael

doi:10.1016/j.jff.2015.05.009

Cited by 33 publications

(27 citation statements)

References 98 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Similar data from murine models with L. rhamnosus GG were reported. Particularly after aflatoxin exposure, lower expression of c-myc, cyclin D1, bcl-2 and rasp-21/g3pdh were found [41].…”

Section: Probiotics In Liver Diseasementioning

confidence: 97%

“…The researchers reported that probiotics can be useful in treating hepatic diseases due to their potential ability to modulate alterations in the gut microbiota, intestinal permeability, and immune and inflammatory responses. More studies based on murine and in vitro models show the role of probiotics in several liver diseases [41]. From medical point of view the pathogenic mechanism involved in liver damage secondary to alcohol abuse is endotoxemia.…”

Section: Probiotics In Liver Diseasementioning

confidence: 99%

“…From medical point of view the pathogenic mechanism involved in liver damage secondary to alcohol abuse is endotoxemia. Researchers reported that through using L. plantarum encapsulated alginate beads induce a dose-dependent reduction of endotoxin level in rats exposed to alcohol [41].…”

Section: Probiotics In Liver Diseasementioning

confidence: 99%

“…Hepatitis viruses, especially B and C, are known to cause long-term hepatocellular injury. As in other hepatic diseases, the plasma level of endotoxin increases in these patients because of changes in the gut microbiota [41]. Several studies evaluated the effects of probiotics in patients with hepatitis B virus (HBV) and hepatitis C virus (HCV).…”

Section: Probiotics In Liver Diseasementioning

confidence: 99%

“…There are limited studies suggesting the role of probiotics for hepatocellular carcinoma. Chávez-Tapia et al [41] reported in his article that clinical data the next probiotics-L. rhamnosus LC705 and Propionibacterium freudenreichii subsp. Shermanii, maybe reduce the biologically effective dose of aflatoxin exposure.…”

Section: Probiotics In Liver Diseasementioning

confidence: 99%

See 4 more Smart Citations

Probiotic, Prebiotic and Synbiotic Products in Human Health

Maftei¹

2019

Frontiers and New Trends in the Science of Fermented Food and Beverages

View full text Add to dashboard Cite

The health benefits imparted by probiotics and prebiotics as well as synbiotics have been the subject of extensive research in the past few decades. What is the real role of probiotics strains, prebiotics and synbiotics in influencing a health? To battle the increase in health care costs, in recent years has been developed a preventive approach to medicine with the development of new probiotics and prebiotics or symbiotic products. Many studies suggest that probiotics, prebiotics and synbiotics supplementation may be beneficial in prevention and management of nutritional and health. While these studies show promising beneficial effects, the long-term risks or health benefits of prebiotics, probiotics and synbiotics supplementation are not clear. In this chapter review the literature regarding available information and summarises the current knowledge on the effects of probiotics, prebiotics, and synbiotics on human health and explore recent trends and developments in this field.

show abstract

“…Similar data from murine models with L. rhamnosus GG were reported. Particularly after aflatoxin exposure, lower expression of c-myc, cyclin D1, bcl-2 and rasp-21/g3pdh were found [41].…”

Section: Probiotics In Liver Diseasementioning

confidence: 97%

Section: Probiotics In Liver Diseasementioning

confidence: 99%

Section: Probiotics In Liver Diseasementioning

confidence: 99%

Section: Probiotics In Liver Diseasementioning

confidence: 99%

Section: Probiotics In Liver Diseasementioning

confidence: 99%

See 3 more Smart Citations

Probiotic, Prebiotic and Synbiotic Products in Human Health

Maftei¹

2019

Frontiers and New Trends in the Science of Fermented Food and Beverages

View full text Add to dashboard Cite

show abstract

Food Hazards and Quality Control in Table Olive Processing with a Special Reference to Functional Compounds

Rahmani¹

2017

Olives and Olive Oil as Functional Foods

View full text Add to dashboard Cite

Lactobacillus coryniformis subsp. torquensT3 alleviates non‐alcoholic fatty liver disease via reconstruction of the gut microbiota and redox system

et al. 2023

View full text Add to dashboard Cite

BACKGROUNDA high‐fat diet (HFD) that induces obesity has become the most common type of diet worldwide, leading to serious global health issues. Obesity is associated with an increased risk of non‐alcoholic fatty liver disease (NAFLD). Probiotic supplements have been shown to help alleviate obesity. The present study aimed to investigate the mechanism by which Lactobacillus coryniformis supsp. torquens T3 (T3L) alleviated NAFLD induced by HFD via reconstruction of the gut microbiota and redox system.RESULTSThe results showed that, compared with the HFD group, T3L inhibited obesity and relieved fat accumulation in the liver of mice with NAFLD. In addition, T3L inhibited liver inflammation and oxidative stress injury in NAFLD mice by regulating the lipopolysaccharide (LPS) inflammatory pathway in the liver. Furthermore, T3L changed the composition of the intestinal flora, reduced the abundance of harmful bacteria in the intestinal tract, enhanced the mechanical function of the intestinal barrier, and increased the short‐chain fatty acid contents, thus inhibiting the secondary metabolite LPS, which directly causes liver damage through the portal vein.CONCLUSIONIn summary, T3L ameliorated NAFLD induced by obesity through the liver–gut axis pathway, thus reducing oxidative stress and liver injury. © 2023 Society of Chemical Industry.

show abstract

Current evidence on the use of probiotics in liver diseases

Cited by 33 publications

References 98 publications

Probiotic, Prebiotic and Synbiotic Products in Human Health

Probiotic, Prebiotic and Synbiotic Products in Human Health

Food Hazards and Quality Control in Table Olive Processing with a Special Reference to Functional Compounds

Lactobacillus coryniformis subsp. torquensT3 alleviates non‐alcoholic fatty liver disease via reconstruction of the gut microbiota and redox system

Contact Info

Product

Resources

About